These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 29023935)
1. Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma. Wang F; Li L; Piontek K; Sakaguchi M; Selaru FM Hepatology; 2018 Mar; 67(3):940-954. PubMed ID: 29023935 [TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicles derived from cancer-associated fibroblasts carry tumor-promotive microRNA-1228-3p to enhance the resistance of hepatocellular carcinoma cells to sorafenib. Zhang Y; Pan Q; Shao Z Hum Cell; 2023 Jan; 36(1):296-311. PubMed ID: 36424471 [TBL] [Abstract][Full Text] [Related]
3. Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP. Yang Y; Mao F; Guo L; Shi J; Wu M; Cheng S; Guo W Dig Liver Dis; 2021 Apr; 53(4):474-485. PubMed ID: 33563583 [TBL] [Abstract][Full Text] [Related]
4. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. Lou G; Song X; Yang F; Wu S; Wang J; Chen Z; Liu Y J Hematol Oncol; 2015 Oct; 8():122. PubMed ID: 26514126 [TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p. Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551 [TBL] [Abstract][Full Text] [Related]
6. Exosome-mediated circTTLL5 transfer promotes hepatocellular carcinoma malignant progression through miR-136-5p/KIAA1522 axis. Liu C; Ren C; Guo L; Yang C; Yu Q Pathol Res Pract; 2023 Jan; 241():154276. PubMed ID: 36528986 [TBL] [Abstract][Full Text] [Related]
7. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis. Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150 [No Abstract] [Full Text] [Related]
8. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. Gao J; Dai C; Yu X; Yin XB; Zhou F J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108 [TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment. Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556 [TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation. Baldari S; Di Rocco G; Magenta A; Picozza M; Toietta G Cells; 2019 Dec; 8(12):. PubMed ID: 31816923 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
13. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway. Fu X; Liu M; Qu S; Ma J; Zhang Y; Shi T; Wen H; Yang Y; Wang S; Wang J; Nan K; Yao Y; Tian T J Exp Clin Cancer Res; 2018 Mar; 37(1):52. PubMed ID: 29530052 [TBL] [Abstract][Full Text] [Related]
14. Extract of Huang X; Chen Y; Zhang X; Li F; Ye H Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841 [No Abstract] [Full Text] [Related]
15. In vitro and in vivo anti-metastatic effect of the alkaliod matrine from Sophora flavecens on hepatocellular carcinoma and its mechanisms. Dai M; Chen N; Li J; Tan L; Li X; Wen J; Lei L; Guo D Phytomedicine; 2021 Jul; 87():153580. PubMed ID: 34029939 [TBL] [Abstract][Full Text] [Related]
16. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10. Xu Y; Lai Y; Cao L; Li Y; Chen G; Chen L; Weng H; Chen T; Wang L; Ye Y RNA Biol; 2021 Oct; 18(10):1408-1423. PubMed ID: 33206588 [TBL] [Abstract][Full Text] [Related]
17. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC. Xu J; Wang Y; Zhang Y; Dang S; He S Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12. Han S; Wang L; Sun L; Wang Y; Yao B; Chen T; Liu R; Liu Q Biomed Pharmacother; 2020 Feb; 122():109754. PubMed ID: 31918285 [TBL] [Abstract][Full Text] [Related]
19. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma. Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136 [TBL] [Abstract][Full Text] [Related]
20. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis. Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]